Αποτελέσματα Αναζήτησης
10 Νοε 2021 · Antiretroviral therapy should be initiated in all pediatric patients living with HIV regardless of age, weight, or sexual maturity. 19 In addition, rapid initiation of ART (i.e., immediate initiation on the day of or within 7 days of HIV diagnosis) is recommended for all children living with HIV. 19 The selection of ART should be individualized ...
18 Ιουλ 2022 · With this in mind, the fifth edition of PADO-HIV aimed to review medium-term and long-term priorities for the development of new drugs and formulations for paediatric HIV treatment and prevention, including a special focus on neonates and new technologies.
11 Απρ 2022 · • The Panel also noted that children with HIV who are relocating from outside the United States may benefit from thyroid function studies and additional evaluations, such as screening for tuberculosis, gastrointestinal parasites, hepatitis infection, and lead level.
18 Μαΐ 2022 · Evidence-based guidance for prevention of vertical HIV transmission during pregnancy, delivery, and breastfeeding has evolved steadily since 2010 leading to improved maternal health, reduced transmission, and improved early diagnosis in children living with HIV.
29 Δεκ 2021 · Methods. We conducted an open-label, randomized, noninferiority trial comparing three-drug ART based on the HIV integrase inhibitor dolutegravir with standard care (non–dolutegravir-based ART)...
16 Ιουν 2020 · On June 12, 2020, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination with other antiretroviral treatments.
21 Ιουν 2023 · The new generation of long-acting or extended-release antiretroviral drugs, including long-acting broadly neutralizing monoclonal antibodies, has great promise for advancing biomedical HIV ...
